Haloperidol (haloperidol lactate) NDC 70518-0035

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-0035Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-0035Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-0035-0	70518003500	25 VIAL in 1 TRAY (70518-0035-0) / 1 mL in 1 VIALMarketed from Dec 2, 2016

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Haloperidol
Generic name (nonproprietary): haloperidol lactate
Active ingredients: Haloperidol lactate — 5 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular
Labeler: REMEDYREPACK INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075689
Marketing start: Dec 2, 2016
Listing expires: Dec 31, 2027
Identifiers: Product ID 70518-0035_4cd54384-6fbc-ee88-e063-6294a90aa4efSPL ID 4cd54384-6fbc-ee88-e063-6294a90aa4efSPL set ID e702b2f0-d464-41c3-977a-d37bb22c0ab0RxCUI 1719646UNII 6387S86PK3
Pharmacologic class: Typical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470518003500 followed by a unit qualifier and the quantity

Package 70518-0035-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 12, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Haloperidol injection is indicated for the treatment of patients with schizophrenia.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 075689

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075689
Product	Strength	Form · route	Labeler	Product NDC
Haloperidolhaloperidol lactate	Haloperidol lactate 5 mg/mL	Injection, SolutionIntramuscular	HF Acquisition Co LLC, DBA HealthFirst	51662-1524
Haloperidolhaloperidol lactate	Haloperidol lactate 5 mg/mL	Injection, SolutionIntramuscular	Cardinal Health 107, LLC	55154-9553
Haloperidolhaloperidol lactate	Haloperidol lactate 5 mg/mL	Injection, SolutionIntramuscular	Fresenius Kabi USA, LLC	63323-474